Comment in

• Peginterferon and ribavirin for hepatitis C.

  Duggan AE, Duggan JM. Duggan AE, et al. N Engl J Med. 2007 Mar 22;356(12):1269; author reply 1271. doi: 10.1056/NEJMc063729. N Engl J Med. 2007. PMID: 17377169 No abstract available.
• Peginterferon and ribavirin for hepatitis C.

  Abramowicz M. Abramowicz M. N Engl J Med. 2007 Mar 22;356(12):1270-1; author reply 1271. N Engl J Med. 2007. PMID: 17378100 No abstract available.
• Peginterferon and ribavirin for hepatitis C.

  Evoli A, Servidei S. Evoli A, et al. N Engl J Med. 2007 Mar 22;356(12):1269-70; author reply 1271. N Engl J Med. 2007. PMID: 17380575 No abstract available.
• Peginterferon and ribavirin for hepatitis C.

  Assy N, Embon O. Assy N, et al. N Engl J Med. 2007 Mar 22;356(12):1269; author reply 1271. N Engl J Med. 2007. PMID: 17380576 No abstract available.
• Peginterferon and ribavirin for hepatitis C.

  Leiner S. Leiner S. N Engl J Med. 2007 Mar 22;356(12):1270; author reply 1271. N Engl J Med. 2007. PMID: 17380577 No abstract available.
• Peginterferon and ribavirin for hepatitis C.

  Ben Salem C, Hmouda H, Bouraoui K. Ben Salem C, et al. N Engl J Med. 2007 Mar 22;356(12):1270; author reply 1271. N Engl J Med. 2007. PMID: 17380578 No abstract available.